Proposed use: Ulcerative colitis Proposed forms: Oral capsules, nasal spray, injections, transdermal cream, rectal suppository Proposed use: Wound healing Proposed forms: Subcutaneous or intramuscular injection Secret To Weight Loss May Be Hiding In Your Gut, New Study Suggests Proposed use: Wound healing and inflammatory condition Proposed forms: Cream and gel Proposed use: Obesity and osteoporosis Proposed forms: Subcutaneous injection Proposed use: Cerebral ischemia (shortage of blood flow and oxygen to the brain), migraine and trigeminal neuralgia (chronic pain condition in the face) Proposed form: Intranasal spray, subcutaneous injection Click Here To Sign Up For Our Health Newsletter Proposed use: Opioid withdrawal, chronic insomnia, narcolepsy Proposed form: Subcutaneous injection Proposed use: Insomnia Advertisement Proposed form: Subcutaneous injection Performance medicine and peptide expert Dr
That means: 0.1 mL on an insulin syringe = 250 mcg 0.2 mL = 500 mcg
For context on the broader microdosing GLP-1 protocols that some athletes may use for non-performance reasons, those discussions also interact with WADA monitoring considerations
Synergism between Luteolin and Sulforaphane in Anti-Inflammation
10.1016/j.virol.2014.05.015 9 BilasyS
11,23 The reduced antioxidant barrier in patients with COVID-19 has been further confirmed by Muhammad et al, who found lower levels of GSH, GPx, and SOD in these patients compared to healthy volunteers
